Charles River Laboratories International Inc. (CRL): Price and Financial Metrics
CRL Price/Volume Stats
Current price | $194.94 | 52-week high | $262.00 |
Prev. close | $194.44 | 52-week low | $181.22 |
Day low | $191.10 | Volume | 403,600 |
Day high | $195.27 | Avg. volume | 524,247 |
50-day MA | $205.15 | Dividend yield | N/A |
200-day MA | $210.81 | Market Cap | 9.99B |
CRL Stock Price Chart Interactive Chart >
CRL POWR Grades
- CRL scores best on the Value dimension, with a Value rank ahead of 68.7% of US stocks.
- The strongest trend for CRL is in Growth, which has been heading down over the past 177 days.
- CRL's current lowest rank is in the Momentum metric (where it is better than 7.67% of US stocks).
CRL Stock Summary
- CRL has a market capitalization of $10,234,788,284 -- more than approximately 84.5% of US stocks.
- For CRL, its debt to operating expenses ratio is greater than that reported by 75.41% of US equities we're observing.
- The volatility of CHARLES RIVER LABORATORIES INTERNATIONAL INC's share price is greater than that of 26.64% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to CRL, based on their financial statements, market capitalization, and price volatility, are EDR, LEA, SDPI, HLIO, and ENV.
- CRL's SEC filings can be seen here. And to visit CHARLES RIVER LABORATORIES INTERNATIONAL INC's official web site, go to www.criver.com.
CRL Valuation Summary
- CRL's price/sales ratio is 2.4; this is 26.32% higher than that of the median Healthcare stock.
- CRL's price/earnings ratio has moved up 2.9 over the prior 243 months.
Below are key valuation metrics over time for CRL.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
CRL | 2023-09-22 | 2.4 | 3.1 | 21.1 | 17.8 |
CRL | 2023-09-21 | 2.4 | 3.1 | 21.0 | 17.7 |
CRL | 2023-09-20 | 2.6 | 3.3 | 22.1 | 18.4 |
CRL | 2023-09-19 | 2.6 | 3.3 | 22.1 | 18.4 |
CRL | 2023-09-18 | 2.6 | 3.3 | 22.3 | 18.6 |
CRL | 2023-09-15 | 2.6 | 3.3 | 22.0 | 18.4 |
CRL Growth Metrics
- The year over year revenue growth rate now stands at 19.34%.
- The 4 year cash and equivalents growth rate now stands at 183.17%.
- The 3 year price growth rate now stands at 91.8%.

The table below shows CRL's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 3,976.06 | 619.64 | 486.226 |
2022-09-30 | 3,781.267 | 614.141 | 436.394 |
2022-06-30 | 3,688.047 | 656.084 | 443.347 |
2022-03-31 | 3,629.523 | 693.2 | 422.474 |
2021-12-31 | 3,540.16 | 760.799 | 390.982 |
2021-09-30 | 3,426.1 | 669.92 | 396.595 |
CRL's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CRL has a Quality Grade of C, ranking ahead of 58.62% of graded US stocks.
- CRL's asset turnover comes in at 0.564 -- ranking 280th of 561 Business Services stocks.
- CRTO, OOMA, and SCWX are the stocks whose asset turnover ratios are most correlated with CRL.
The table below shows CRL's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-26 | 0.564 | 0.379 | 0.141 |
2021-03-27 | 0.559 | 0.371 | 0.139 |
2020-12-26 | 0.553 | 0.367 | 0.135 |
2020-09-26 | 0.555 | 0.367 | 0.119 |
2020-06-27 | 0.558 | 0.361 | 0.101 |
2020-03-28 | 0.570 | 0.367 | 0.096 |
CRL Price Target
For more insight on analysts targets of CRL, see our CRL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $448.00 | Average Broker Recommendation | 1.35 (Strong Buy) |
Charles River Laboratories International Inc. (CRL) Company Bio
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry (for example, contract research organization services) and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing. (Source:Wikipedia)
Latest CRL News From Around the Web
Below are the latest news stories about CHARLES RIVER LABORATORIES INTERNATIONAL INC that investors may wish to consider to help them evaluate CRL as an investment opportunity.
Unveiling Charles River Laboratories International's Value: Is It Really Priced Right? A ...Deciphering the intrinsic value of Charles River Laboratories International (CRL) based on its financial strength, profitability, and future growth prospects |
Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage BioclusterSTEVENAGE, United Kingdom, September 25, 2023--Charles River opens purpose-built lab offering GMP QC test capabilities to Stevenage biocluster. |
Unveiling Charles River Laboratories International (CRL)'s Value: Is It Really Priced Right? A ...Charles River Laboratories International Inc (NYSE:CRL) recently experienced a daily loss of -5.21%, and a 3-month loss of -0.43%. This article aims to answer that question through a detailed valuation analysis of Charles River Laboratories International (NYSE:CRL). Established in 1947, Charles River Laboratories International Inc (NYSE:CRL) is a leading provider of drug discovery and development services. |
Charles River Laboratories to Host Virtual Investor DayWILMINGTON, Mass., September 20, 2023--Charles River Laboratories to Host Investor Day on September 21, 2023 |
Unpacking the Investment Potential of Charles River Laboratories International Inc (CRL): A ...Exploring the robust financial stance and growth prospects of Charles River Laboratories International Inc (CRL) |
CRL Price Returns
1-mo | -4.39% |
3-mo | -7.28% |
6-mo | -3.41% |
1-year | 4.01% |
3-year | -12.75% |
5-year | 44.89% |
YTD | -10.54% |
2022 | -42.17% |
2021 | 50.80% |
2020 | 63.56% |
2019 | 34.97% |
2018 | 3.41% |
Continue Researching CRL
Want to do more research on Charles River Laboratories International Inc's stock and its price? Try the links below:Charles River Laboratories International Inc (CRL) Stock Price | Nasdaq
Charles River Laboratories International Inc (CRL) Stock Quote, History and News - Yahoo Finance
Charles River Laboratories International Inc (CRL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...